The 25 references in paper A. Fursov A., A. Salmina B., S. Mikhutkina V., L. Zykova D., N. Malinovskaya A., A. Morgun V., D. Laletin I., M. Fursov A., G. Yudin V., N. Shnayder A., S. Shakhmaeva V., А. Фурсов А., А. Салмина Б., С. Михуткина В., Л. Зыкова Д., Н. Малиновская А., А. Моргун В., Д. Лалетин И., М. Фурсов А., Г. Юдин В., Н. Шнайдер А., С. Шахмаева В. (2007) “Профилактика постишемического неврологического дефицита путем модуляции экспрессии АДФ-рибозилциклазы в клетках головного мозга (экспериментальное исследование) // Prevention of Postischemic Neurological Deficit by Modulating the Cerebral Cell Expression of ADP-Ribosyl Cyclase (Experimental Study)” / spz:neicon:reanimatology:893

1
Li J. !H.Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue dam! age. US patent 2001; 6 (291): 425.
(check this in PDF content)
2
Ижбульдин Р. И., Плечев В. В., Закиров И. Р., Фархутдилов Р. Р. Спо! соб защиты головного мозга в реконструктивной хирургии сонных артерий. 2004. патент РФ 2279878, МПК A61K 31/455, A61P 9/10, 20.07.2006
(check this in PDF content)
3
Simpkins J. W., Gordon K. D., Leonard R. J.Methods of prevention and treatment of ischemic damage. US patent 6,339,078 (2002).
(check this in PDF content)
4
Gee K. W. Use of peripheral!type benzodiazpine sites for treatment of CNS trauma or disease, US patent 5,550,124 (1996).
(check this in PDF content)
5
Lubitz V., Kenneth A., Jacobson D. K.Method of treating ischemic, hypoxic and anoxic brain damage. US patent 6,316,423 (2001).
(check this in PDF content)
6
Прайс Д. Трансплантация гемопоэтических клеток. 2003, патент РФ 2216336, МПК A61K 35/48, A61P 25/00, 20.11.2003
(check this in PDF content)
7
Ran Z. !H., Rayet B., Rommelaere J. et al.Parvovirus H1!induced cell death: influence of intracellular NAD consumption on the regulation of necrosis and apoptosis. Virus Res. 1999; (65): 161—174.
(check this in PDF content)
8
Berger F., Lau C., Dahlmann M. et al. Subcellular compartmentation and different catalytic properties of three human nicotinamide mononu! cleotide adenylyltransferase isoforms. J. Biol. Chem. 2005; 280 (43): 36334—36341.
(check this in PDF content)
9
Magni G., Amici A., Emanuelli M. et al.Enzymology of NAD+ home! ostasis in man. Cell. Mol. Life Sci. 2004; (61): 19—34.
(check this in PDF content)
10
Aksoy P., White T., Thompson M. et al.Regulation of intracellular levels of NAD: a novel role for CD38. Biochem. Biophys. Res. Comm. 2006; (10): 1016; 2006; (05): 042.
(check this in PDF content)
11
Berthelier V., Tixier J. !M., Muller!Steffner H. et al.Human CD38 is an authentic NAD(P)+ glycohydrolase. Biochem. J.1998; 330: 1383—1390.
(check this in PDF content)
12
Ceni C., Muller!Steffner H., Lund F. et al.Evidence for a intracellular ADP!ribosyl cyclase/NAD glycohydrolase in brain from CD38!defi! cient mice. J.Biol.Chem. 2003; 278 (42): 40670—40678.
(check this in PDF content)
13
Flora A., Franco L., Guida L. et al.Ectocellular CD38!catalyzed syn! thesis and intracellular Ca2+! mobilizing activity of cyclic ADP!ribose. Cell Biochem. Biophys. 1998; 28 (1): 45—62.
(check this in PDF content)
14
Guida L., Bruzzone S., Sturla L. et al.Equilibrative and concentrative nucleoside transporters mediate influx of extracellular cyclic ADP! ribose into 3T3 murine fibroblasts. J. Biol. Chem. 2002; 277 (49): 47097—47105.
(check this in PDF content)
15
Hashii M., Munabe Y., Higashida H.cADP!ribose potentiates cytosolic Ca2+elevation and Ca2+entry via L!type voltage!activated Ca2+chan! nels in NG108!15 neuronal cells. Biochem. J. 2000; 345: 207—215.
(check this in PDF content)
16
Higashida H., Hashii M., Yokoyama S. et al.Cyclic ADP!ribose as a sec! ond messenger revisited from a new aspect of signal transduction from receptors to ADP!ribosyl cyclase. Phramacol. & Therapeutics 2001; 90: 283—296.
(check this in PDF content)
17
Ceni C., Pochon N., Brun V. et al.CD38!dependent ADP!ribosyl cyclase activity in developing and adult mouse brain. Biochem. J. 2003; 370: 175—183.
(check this in PDF content)
18
Ceni C., Pochon N., Villaz M. et al. The CD38!independent ADP!ribosyl cyclase from mouse brain synaptosomes: a comparative study of neonate and adult brain. Biochem. J. 2006; 395: 417—426.
(check this in PDF content)
19
Ya m a d a M . , M i z u g u s h i M . , O t s u k a N . e t a l .Ultrastructural localization of CD38 immunoreactivity in rat brain. Brain Res. 1997; 756 (1—2): 52—60.
(check this in PDF content)
20
Kunz S., Rojek J. M., Roberts A. J. et al.Altered central nervous system gene expression caused by congenitally aquired persistent infection with lymphocytic choriomeningitis virus. J. Virology 2006; 80 (18): 9082—9092.
(check this in PDF content)
21
Maier C. M., Yu F., Nishi T. et al.Interferon!beta fails to protect in a model of transient focal stroke. Stroke 2006; 37: 1116.
(check this in PDF content)
22
Yilmaz G., Arumugam T. V., Stokes K. Y. et al. Role of T lymphocytes and interferon!gamma in ischemic stroke. Circulation 2006; 113: 2105— 2112.
(check this in PDF content)
23
Hajilambreva G., Mix E., Rolfs A. et al.Neuromodulation by a cytokine: interferon!beta differentially augments neocortical neuronal activity and excitability. J. Neurophysiol. 2005; 93: 843—852.
(check this in PDF content)
24
Koh J. !Y., Wie M. B., Gwag B. J. et al.Staurosporine!induced neuronal apoptosis. Exp. Neurol. 1995; 135: 153—159.
(check this in PDF content)
25
Bauvois B., Durant L., Laboureau J. et al.Upregulation of CD38 gene expression in leukemic B cells by interferon types I and II. J. Interferon Cytokine Res. 1999; 19: 1059—1066. Поступила 08.06.07
(check this in PDF content)